Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.750
-0.230 (-11.62%)
At close: Sep 4, 2026, 4:00 PM EDT
1.670
-0.080 (-4.57%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.19 million as of September 4, 2026. Its market cap has increased by 49.20% in one year.
Market Cap
6.19M
Enterprise Value
227.37K
1-Year Change
49.20%
Ranking
Category
Stock Price
$1.75
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.19M, an increase of 24.60%. That is a compound annual growth rate of 1.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 6.19M | -11.47% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 7.11M |
| Creative Medical Technology Holdings | 6.99M |
| CollPlant Biotechnologies | 6.45M |
| Enveric Biosciences | 6.45M |
| XTL Biopharmaceuticals | 6.21M |
| NuCana | 6.16M |
| Processa Pharmaceuticals | 5.73M |
| Kairos Pharma | 5.65M |